// App-Quantinova.ai

1346 : Anti-NT5c1A Autoantibodies As Biomarkers in Inclusion Body Myositis

Researchers

Presenter

  • Mark Tarnopolsky

Principal Investigators

  • Lauren Brady

  • Ignacio Garcia de la Torre

  • Michael Mahler

  • May Choi

  • Marvin J. Fritzler

Medical Centers

  • Internal Medicine, University of Calgary, Calgary, AB, Canada

  • Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario, Canada

  • Universidad de Guadalajara, Guadalajara, Mexico

  • Research and Development, Inova Diagnostics, San Diego, CA, United States

  • Department of Surgery and Oncology, Faculty of Medicine, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

  • Mexico

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • N/A

Biomarkers

  • Immunoglobulin G

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A